Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine as Adjunctive Treatment in MDD
NCT01670019Phase 4Completed
- Sponsor
- Duke University
- Start
- Oct 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of asenapine in major depressive disorder (MDD), sponsored by Duke University. Started Oct 2012; status: completed.
02
Drugs
asenapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01670019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670019.